Being an external test there are no clinical considerations like side effects so there won’t be the clinical studies and information that others may have to review and so forth. You would think that would make the process on the shorter time line.
- Forums
- ASX - By Stock
- Ann: Proteomics raises $3m in heavily oversubscribed Placement
PIQ
proteomics international laboratories ltd
Add to My Watchlist
0.00%
!
30.5¢

Being an external test there are no clinical considerations like...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.87M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.5¢ | 7000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.310 |
1 | 3253 | 0.305 |
2 | 3363 | 0.300 |
1 | 10172 | 0.295 |
1 | 150000 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.275 | 7000 | 1 |
0.300 | 12700 | 2 |
0.305 | 24764 | 2 |
0.325 | 9000 | 2 |
0.330 | 57411 | 2 |
Last trade - 09.28am 26/06/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online